Skip to content

Insider · CIK 0001553231

Laurie J Olson

director

Files at QTRX (Quanterix Corp), KRTX (Karuna Therapeutics, Inc.). First filing Oct 12, 2022, latest May 14, 2024.

In brief

Laurie J Olson files SEC Form 4 as director at QTRX (Quanterix Corp), and also at KRTX (Karuna Therapeutics, Inc.). Since Oct 12, 2022, Laurie J Olson has reported 0 open-market buys worth $0 and 6 open-market sells worth $351k, the latest filed on May 14, 2024.

A track record needs three past buys with six months of prices behind them; Laurie J Olson has 0, so none is measured yet.

The newest scored trade: sold $25k of QTRX on May 14, 2024, filed May 14, 2024, scored 0 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $351k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

QTRX: Quanterix Corp

QTRXOct 12, 2026 · close 3.16

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
QTRXsell10b5-1
Quanterix Corp
$25k
1,500 shares
-10%+8% from low-41% from high
0Weak
QTRXsell10b5-1
Quanterix Corp
$24k
1,000 shares
-6%+113% from low-17% from high
1Weak
QTRXsell10b5-1
Quanterix Corp
$37k
1,500 shares
-9%+144% from low-14% from high
0Weak
QTRXsell10b5-1
Quanterix Corp
$27k
1,000 shares
-6%+168% from low-5% from high
1Weak
QTRXsell10b5-1
Quanterix Corp
$33k
1,500 shares
-10%+124% from low-19% from high
20Weak
KRTXsell 210b5-1
Karuna Therapeutics, Inc.
$206k
1,000 shares
-100%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 12, 2024 QTRX
QUANTERIX CORPORATION
20,915
0.05% of outstanding
$378kJun 12, 2024$49k
Apr 1, 2024 QTRX
QUANTERIX CORPORATION
1,000
0.00% of outstanding
$24kApr 1, 2024$63k
Feb 14, 2024 QTRX
QUANTERIX CORPORATION
1,500
0.00% of outstanding
$37kFeb 14, 2024$27k
Jan 2, 2024 QTRX
QUANTERIX CORPORATION
1,000
0.00% of outstanding
$27kJan 2, 2024$33k

Transactions

Every row this insider has filed, 20 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 14, 2024QTRX
Quanterix Corp
SOpen-market sale
Common Stock10b5-1
-1,500$16.98$25k13,738May 14, 2024
Apr 1, 2024QTRX
Quanterix Corp
MOption exercise
Common Stock10b5-1
+1,000$12.86$13k16,238Apr 2, 2024
Apr 1, 2024QTRX
Quanterix Corp
SOpen-market sale
Common Stock10b5-1
-1,000$23.50$24k15,238Apr 2, 2024
Apr 1, 2024QTRX
Quanterix Corp
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,000$0.00$010,124Apr 2, 2024
Mar 18, 2024KRTX
Karuna Therapeutics, Inc.
DDisposition to issuer
Common Stock
-990$330.00$327k0Mar 18, 2024
Mar 18, 2024KRTX
Karuna Therapeutics, Inc.
DDisposition to issuer
Option (right to buy)derivative
-13,000$245.14$3.2M0Mar 18, 2024
Mar 18, 2024KRTX
Karuna Therapeutics, Inc.
DDisposition to issuer
Option (right to buy)derivative
-8,500$201.99$1.7M0Mar 18, 2024
Mar 18, 2024KRTX
Karuna Therapeutics, Inc.
DDisposition to issuer
Option (right to buy)derivative
-5,000$227.04$1.1M0Mar 18, 2024
Mar 18, 2024KRTX
Karuna Therapeutics, Inc.
DDisposition to issuer
Option (right to buy)derivative
-1,904$92.30$176k0Mar 18, 2024
Feb 14, 2024QTRX
Quanterix Corp
SOpen-market sale
Common Stock10b5-1
-1,500$24.35$37k15,238Feb 15, 2024
Jan 2, 2024QTRX
Quanterix Corp
AGrant or award
Common Stock
+2,947$0.00$016,738Jan 4, 2024
Jan 2, 2024QTRX
Quanterix Corp
MOption exercise
Common Stock
+1,000$12.86$13k17,738Jan 4, 2024
Jan 2, 2024QTRX
Quanterix Corp
SOpen-market sale
Common Stock10b5-1
-1,000$26.91$27k16,738Jan 4, 2024
Jan 2, 2024QTRX
Quanterix Corp
AGrant or award
Stock Option (Right to Buy)derivative
+6,412$0.00$06,412Jan 4, 2024
Jan 2, 2024QTRX
Quanterix Corp
MOption exercise
Stock Option (Right to Buy)derivative
-1,000$0.00$011,124Jan 4, 2024
Nov 14, 2023QTRX
Quanterix Corp
SOpen-market sale
Common Stock10b5-1
-1,500$21.89$33k13,791Nov 14, 2023
Oct 11, 2022KRTX
Karuna Therapeutics, Inc.
MOption exercise
Common Stock
+1,000$84.86$85k1,000Oct 12, 2022
Aug 15, 2022KRTX
Karuna Therapeutics, Inc.
MOption exercise
Option (right to buy)derivative
-1,000$0.00$017,000Oct 12, 2022
Oct 11, 2022KRTX
Karuna Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-1,000$205.63$206k0Oct 12, 2022
Oct 11, 2022KRTX
Karuna Therapeutics, Inc.
MOption exercise
Option (right to buy)derivative
-1,000$0.00$016,000Oct 12, 2022

Questions about Laurie J Olson

Answered from the filings on this page, as of the latest one.

Is Laurie J Olson buying or selling?

Not in the last 12 months. Laurie J Olson's latest open-market trade on SEC Form 4 was sold $25k of QTRX on May 14, 2024.

How did Laurie J Olson's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Laurie J Olson has 0.

Where does Laurie J Olson file Form 4?

Laurie J Olson has filed Form 4 at QTRX (Quanterix Corp); KRTX (Karuna Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Laurie J Olson: insider trades and track record | InsiderTell